This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferry, T.
Right arrow Articles by Etienne, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferry, T.
Right arrow Articles by Etienne, J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, July 2006, p. 2642-2644, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00430-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Toxin Gene Content of the Lyon Methicillin-Resistant Staphylococcus aureus Clone Compared with That of Other Pandemic Clones

Tristan Ferry,* Michèle Bes, Olivier Dauwalder, Hélène Meugnier, Gerard Lina, Françoise Forey, François Vandenesch, and Jerome Etienne

Centre National de Référence des Staphylocoques, INSERM E0230, IFR 62, Faculté de Médecine Laennec, 7 rue Guillaume Paradin, 69008 Lyon, France

Received 27 February 2006/ Returned for modification 5 April 2006/ Accepted 23 April 2006


arrow
ABSTRACT
 
The methicillin-resistant Staphylococcus aureus (MRSA) Lyon clone, detected throughout France, contains the enterotoxin A gene (sea), like other pandemic clones of clonal complex 8 (CC8). The egc locus was detected in MRSA pandemic clones of CC5, CC22, and CC45, occasionally with the toxic shock syndrome toxin 1 gene. The representative strain of the EMRSA-16 clone (CC30) harbored both sea and the egc locus.


arrow
TEXT
 
Methicillin-resistant Staphylococcus aureus (MRSA) strains are spreading through hospitals worldwide and are the leading hospital-acquired pathogen (1, 2). Population genetics studies based on multilocus sequence typing (MLST) have shown that major MRSA clones have emerged from five clonal complexes (CCs): CC5, CC8, CC22, CC30, and CC45 (16). Within each CC, prevalent clones (the Archaic clone, the Iberian clone, and the German clone, for example) have been genetically characterized by their sequence type, their spa type, and their SCCmec cassette (13). In France, the gentamicin-resistant Iberian clone was the major MRSA clone in the 1990s (11). Since 1992, French MRSA isolates have been increasingly susceptible to gentamicin, indicating a gradual decline of the Iberian clone (11).

MRSA clones have been characterized on the basis of several other characteristics. For instance, MRSA detected in Japan was shown to produce toxic shock syndrome toxin 1, a superantigenic toxin family member (7, 15). Moreover, Peacock et al. showed that the prevalence of the staphylococcal enterotoxin A gene (sea) was higher in invasive infections due to one of the MRSA clones (EMRSA-16) that predominate in the United Kingdom (14). Up to now, 18 superantigenic toxins have been described for S. aureus (7), but the distribution of the genes encoding superantigenic toxins is not known for all MRSA pandemic clones.

The aim of this study was to characterize the superantigenic gene content of the French and major pandemic MRSA clones. The study was conducted in three steps: (i) a local study characterizing MRSA isolates collected by blood culture in 2003 in intensive care units of Edouard Herriot Hospital in Lyon, France, permitting the recognition of the major MRSA clone; (ii) a nationwide study of the spread of the major clone identified in Lyon (designated the Lyon clone); (iii) a worldwide study comparing the characteristics and toxin gene content of the Lyon clone and the major pandemic MRSA clones.

All S. aureus isolates included in this study were identified by means of standard microbiological methods, and drug resistance was determined by using the Phoenix Automated Microbiology System (BD Biosciences). MRSA isolates were first genetically characterized by means of MLST as described by Enright et al. (4, 5). spa types were determined with the assistance of Ridom Staph Type software (Ridom GmbH, Würzburg, Germany [http://www.ridom.de/staphtype/]) (6). Pulsed-field gel electrophoresis patterns were prepared as previously described (17) and were digitized and analyzed with the Taxotron typing system (Institut Pasteur, France). The accessory gene regulator (agr) allele group (1 to 4), the presence of the mecA gene, and the toxin gene content were determined by multiplex PCR as previously described (8-10). The type of the staphylococcal chromosomal cassette (SCCmec) was determined as described by Oliveira and de Lencastre (12).

In 2003, 17 MRSA blood isolates were collected at Edouard Herriot Hospital in Lyon, France. They belonged to a major lineage, designated sequence type 8 (ST8) (14 isolates), and a minor lineage, designated ST5 (3 isolates). Clone ST8, named the Lyon clone, included 13 of the 14 ST8 isolates. This clone shared ST8 within the CC8, spa type t008 or a minor variation of spa type t008 (t068 or t569, as shown in Table 1), agr allele type 1, the sea gene, the leucocidin lukE-lukD genes, the hemolysin hlgv gene, and the SCCmec type IVA cassette. The staphylococcal enterotoxin B and D genes (seb and sed) were not detected in all of the isolates. Almost all of the Lyon clone isolates were resistant to penicillin, oxacillin, kanamycin, tobramycin, erythromycin, and ofloxacin. One ST8 isolate (HT20040113) was not considered to belong to the Lyon clone, owing to the multiple variations of the spa type and to the absence of the sea gene (Table 1). Two of the three ST5 MRSA isolates contained the tst gene and corresponded to an emerging MRSA clone related to the New York/Japan (NY/J) clone (3).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Clonal complexes, spa types, and spa repeats of MRSA clonesa

Since our multiplex PCR method based on the detection of more than 15 virulence factor genes and the agr gene regulator reveals the genetic background of a given strain (9), we considered that hospital-acquired MRSA strains sharing the agr-1, sea, lukE-lukD, and hlgv genes potentially belonged to the Lyon clone. To evaluate the spread of the Lyon clone throughout France, we analyzed the 2001 to 2005 database of the French National Reference Center for staphylococci, excluding Panton-Valentine-leucocidin-positive MRSA isolates, which belong to community-acquired MRSA clones. We selected 320 Panton-Valentine-leucocidin-negative MRSA isolates, of which 165 (51.6%), from 20 French towns, matched the characteristics of the Lyon clone. Thirty-two of these isolates were fully characterized by MLST and spa typing. They were ST8 and had an SCCmec cassette of type IVA (except for two strains, which had an SCCmec cassette of type IV) and spa type t008, t024, t068, t121, t569 or t681 (all considered minor variants of the major spa type t008, differing by a single repeat [t024, t068, t121, and t681] or two repeats [t569]), confirming that they belonged to the Lyon clone. This suggests that the Lyon clone is present throughout France.

We then compared the characteristics of the Lyon clone with those of other pandemic MRSA clones (Fig. 1). The Lyon clone and New York clone V belonged to CC8, were ST8, and had an agr type 1 allele, a similar toxin gene profile, and related spa types. Other MRSA clones of CC8 had an agr-1 allele. The sea gene was also detected in representatives of the Iberian and Hungarian clones. All representatives of MRSA clones belonging to CC5, CC22, and CC45 shared the enterotoxin gene cluster locus (egc) encoding five superantigenic enterotoxin genes (seg, sei, sem, sen, and seo) and occasionally the tst gene. The representative strain of the EMRSA-16 clone, which represents CC30, shared both the sea gene and the egc locus. The Brazilian clone was the only clone that lacked all of the tested superantigenic toxin genes. Note that all strains of the same CC had the same agr allele [1, 2, or 3].


Figure 1
View larger version (37K):
[in this window]
[in a new window]
  		FIG. 1. Dendrogram constructed from the schematic representation of the pulsed-field gel electrophoresis types of pandemic MRSA clones and other MRSA isolates included in this study together with their genetic characteristics, such as ST, spa type, SCCmec type, agr allele group, and toxin gene content (sea-sed, staphylococcal enterotoxin A to D genes; sel, staphylococcal enterotoxin L gene; egc, enterotoxin gene cluster; tst, toxic shock syndrome toxin 1 gene). CCs were assigned according to the MLST database at http://www.mlst.net. Blue isolates correspond to the Lyon clone and red isolates to an emerging clone (3). Drug resistance is given in parentheses (KAN, kanamycin; TOB, tobramycin; GEN, gentamicin; ERY, erythromycin; CLI, clindamycin; OFX, ofloxacin; SXT, trimethoprim-sulfamethoxazole; FUS, fusidic acid; FOF, fosfomycin). NT, nontypeable. The fragment size (kb) of the reference strain NCTC8325 is indicated on the bottom line.

In conclusion, the Lyon clone is detected all over France and is related to other pandemic MRSA clones that share the sea gene. With the exception of the Brazilian clone, all pandemic MRSA clones contain at least one gene encoding a superantigenic toxin. Superantigenic toxins could partly account for the virulence of hospital-acquired MRSA infections.


arrow
ACKNOWLEDGMENTS
 
We thank H. de Lencastre, A. Tomasz, and J. Perry for kindly providing pandemic MRSA reference strains; Christine Gardon, Christine Courtier, and Céline Spinelli (Centre National de Référence des Staphylocoques) for their technical support; and David Young for editorial assistance.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Centre National de Référence des Staphylocoques, INSERM E0230, IFR 62, Faculté de Médecine Laennec, 7 rue Guillaume Paradin, 69008 Lyon, France. Phone: 33(0)-478-77-86-57. Fax: 33(0)-478-77-86-58. E-mail: tristan.ferry{at}univ-lyon1.fr. Back


arrow
REFERENCES
 
    1
  1. Astiz, M. E., and E. C. Rackow. 1998. Septic shock. Lancet 351:1501-1505.[CrossRef][Medline]
    2. 2
  2. Brun-Buisson, C., P. Meshaka, P. Pinton, and B. Vallet. 2004. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 30:580-588.[CrossRef][Medline]
    3. 3
  3. Durand, G., M. Bes, H. Meugnier, M. C. Enright, F. Forey, N. Liassine, A. Wenger, K. Kikuchi, G. Lina, F. Vandenesch, and J. Etienne. 2006. Detection of new methicillin-resistant Staphylococcus aureus clones containing the toxic shock syndrome toxic shock syndrome 1 gene responsible for hospital- and community-acquired infections in France. J. Clin. Microbiol. 44:847-853.[Abstract/Free Full Text]
    4. 4
  4. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.[Abstract/Free Full Text]
    5. 5
  5. Enright, M. C., and B. G. Spratt. 1999. Multilocus sequence typing. Trends Microbiol. 7:482-487.[CrossRef][Medline]
    6. 6
  6. Harmsen, D., H. Claus, W. Witte, J. Rothganger, D. Turnwald, and U. Vogel. 2003. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41:5442-5448.[Abstract/Free Full Text]
    7. 7
  7. Holtfreter, S., and B. M. Broker. 2005. Staphylococcal superantigens: do they play a role in sepsis? Arch. Immunol. Ther. Exp. (Warsaw) 53:13-27.
    8. 8
  8. Jarraud, S., G. Cozon, F. Vandenesch, M. Bes, J. Etienne, and G. Lina. 1999. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J. Clin. Microbiol. 37:2446-2449.[Abstract/Free Full Text]
    9. 9
  9. Jarraud, S., C. Mougel, J. Thioulouse, G. Lina, H. Meugnier, F. Forey, X. Nesme, J. Etienne, and F. Vandenesch. 2002. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70:631-641.[Abstract/Free Full Text]
    10. 10
  10. Jarraud, S., M. A. Peyrat, A. Lim, A. Tristan, M. Bes, C. Mougel, J. Etienne, F. Vandenesch, M. Bonneville, and G. Lina. 2001. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J. Immunol. 166:669-677.[Abstract/Free Full Text]
    11. 11
  11. Lelièvre, H., G. Lina, M. K. Jones, C. Olive, F. Forey, M. Roussel- Delvallez, M. H. Nicolas-Chanoine, C. M. Bébéar, V. Jarlier, A. Andremont, F. Vandenesch, and J. Etienne. 1999. Emergence and spread in French hospital of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamycin and other antibiotics. J. Clin. Microbiol. 37:3452-3457.[Abstract/Free Full Text]
    12. 12
  12. Oliveira, D. C., and H. de Lencastre. 2002. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2155-2161.[Abstract/Free Full Text]
    13. 13
  13. Oliveira, D. C., A. Tomasz, and H. de Lencastre. 2002. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus. Lancet Infect. Dis. 2:180-189.[CrossRef][Medline]
    14. 14
  14. Peacock, S. J., C. E. Moore, A. Justice, M. Kantzanou, L. Story, K. Mackie, G. O'Neill, and N. P. Day. 2002. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70:4987-4996.[Abstract/Free Full Text]
    15. 15
  15. Piao, C., T. Karasawa, K. Totsuka, T. Uchiyama, and K. Kikuchi. 2005. Prospective surveillance of community-onset and healthcare-associated methicillin-resistant Staphylococcus aureus isolated from a university-affiliated hospital in Japan. Microbiol. Immunol. 49:959-970.[Medline]
    16. 16
  16. Robinson, D. A., and M. C. Enright. 2003. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:3926-3934.[Abstract/Free Full Text]
    17. 17
  17. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.[Medline]

Journal of Clinical Microbiology, July 2006, p. 2642-2644, Vol. 44, No. 7
0095-1137/06/$08.00+0     doi:10.1128/JCM.00430-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Sotto, A., Lina, G., Richard, J.-L., Combescure, C., Bourg, G., Vidal, L., Jourdan, N., Etienne, J., Lavigne, J.-P. (2008). Virulence Potential of Staphylococcus aureus Strains Isolated From Diabetic Foot Ulcers: A new paradigm. Diabetes Care 31: 2318-2324 [Abstract] [Full Text]  
  • Karauzum, H., Ferry, T., de Bentzmann, S., Lina, G., Bes, M., Vandenesch, F., Schmaler, M., Berger-Bachi, B., Etienne, J., Landmann, R. (2008). Comparison of Adhesion and Virulence of Two Predominant Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Clones and Clonal Methicillin-Susceptible S. aureus Isolates. Infect. Immun. 76: 5133-5138 [Abstract] [Full Text]  
  • Dauwalder, O., Lina, G., Durand, G., Bes, M., Meugnier, H., Jarlier, V., Coignard, B., Vandenesch, F., Etienne, J., Laurent, F. (2008). Epidemiology of Invasive Methicillin-Resistant Staphylococcus aureus Clones Collected in France in 2006 and 2007. J. Clin. Microbiol. 46: 3454-3458 [Abstract] [Full Text]  
  • Donnio, P.-Y., Fevrier, F., Bifani, P., Dehem, M., Kervegant, C., Wilhelm, N., Gautier-Lerestif, A.-L., Lafforgue, N., Cormier, M., the MR-MSSA Study Group of the College de Bacterio, , Le Coustumier, A. (2007). Molecular and Epidemiological Evidence for Spread of Multiresistant Methicillin-Susceptible Staphylococcus aureus Strains in Hospitals. Antimicrob. Agents Chemother. 51: 4342-4350 [Abstract] [Full Text]  
  • Holtfreter, S., Grumann, D., Schmudde, M., Nguyen, H. T. T., Eichler, P., Strommenger, B., Kopron, K., Kolata, J., Giedrys-Kalemba, S., Steinmetz, I., Witte, W., Broker, B. M. (2007). Clonal Distribution of Superantigen Genes in Clinical Staphylococcus aureus Isolates. J. Clin. Microbiol. 45: 2669-2680 [Abstract] [Full Text]  
  • Mayor, L., Ortellado, J., Menacho, C., Lird, G., Courtier, C., Gardon, C., Meugnier, H., Bes, M., Vandenesch, F., Etienne, J. (2007). Molecular Characterization of Methicillin-Resistant Staphylococcus aureus Isolates Collected in Asuncion, Paraguay. J. Clin. Microbiol. 45: 2298-2300 [Abstract] [Full Text]  
  • Verdier, I., Durand, G., Bes, M., Taylor, K. L., Lina, G., Vandenesch, F., Fattom, A. I., Etienne, J. (2007). Identification of the Capsular Polysaccharides in Staphylococcus aureus Clinical Isolates by PCR and Agglutination Tests. J. Clin. Microbiol. 45: 725-729 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferry, T.
Right arrow Articles by Etienne, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferry, T.
Right arrow Articles by Etienne, J.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»